Cannabigerol Exerts In Vivo and In Vitro Anti-Inflammatory Effects via Inhibition of the MAPK and NF-κB Pathways
Abstract Cannabis sativa L. has a long history of use and contains more than 80 cannabinoids. However, although cannabigerol (CBG),…
Abstract Cannabis sativa L. has a long history of use and contains more than 80 cannabinoids. However, although cannabigerol (CBG),…
Abstract Introduction: Relative humidity (RH) is critical for regulating transpiration, plant morphology, and the biosynthesis of secondary metabolites in crops.…
Abstract Melanogenesis, the key biological process underlying skin hyperpigmentation, is tightly regulated by complex molecular signaling pathways. Consequently, targeting molecular…
Abstract Cannabichromene (CBC: C21H3O2, M.W.: 314.46 g) is a non-psychotropic phytocannabinoid derived from Cannabis sativa (hemp), and its potential therapeutic…
Abstract The search for more effective and safer cancer therapies has led to an increasing interest in combination treatments that…
Abstract Objectives: To determine growth inhibitory and anti-cancer effects of Cannabigerol (CBG) in human colorectal cancer cells. Methods: Anti-proliferative effect…
Abstract As molecular research on hemp (Cannabis sativa L.) continues to advance, there is a growing need for the accumulation…
Abstract Cannabinoid decarboxylation via thermo-chemical conversion has the potential to reduce the cannabinoid degradation and evaporation due to short reaction…
Abstract Cannabichromene (CBC), a non-psychoactive cannabinoid found in Cannabis sativa, has recently been shown to possess several medicinal properties. However,…
Abstract Cannabidiol (CBD) is a chemical obtained from Cannabis sativa; it has therapeutic effects on anxiety and cognition and anti-inflammatory…